18 May 2013
Keywords: fda, warns, az, off-label, promotion, case, anglo-swedish
Article | 15 December 2008
Anglo-Swedish drug major AstraZeneca has received a warning letter from US regulators after an unidentified sales representative pitched one of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 December 2008
17 May 2013
© 2013 thepharmaletter.com